These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11413080)

  • 1. Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease.
    Blankenberg S; Rupprecht HJ; Bickel C; Espinola-Klein C; Rippin G; Hafner G; Ossendorf M; Steinhagen K; Meyer J
    Circulation; 2001 Jun; 103(24):2915-21. PubMed ID: 11413080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease.
    Muhlestein JB; Horne BD; Carlquist JF; Madsen TE; Bair TL; Pearson RR; Anderson JL
    Circulation; 2000 Oct; 102(16):1917-23. PubMed ID: 11034939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin therapy interacts with cytomegalovirus seropositivity and high C-reactive protein in reducing mortality among patients with angiographically significant coronary disease.
    Horne BD; Muhlestein JB; Carlquist JF; Bair TL; Madsen TE; Hart NI; Anderson JL;
    Circulation; 2003 Jan; 107(2):258-63. PubMed ID: 12538425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children.
    Hussain T; Burch M; Fenton MJ; Whitmore PM; Rees P; Elliott M; Aurora P
    Circulation; 2007 Apr; 115(13):1798-805. PubMed ID: 17353448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease: sex-based differences in inflammation and type of immune response.
    Zhu J; Shearer GM; Norman JE; Pinto LA; Marincola FM; Prasad A; Waclawiw MA; Csako G; Quyyumi AA; Epstein SE
    Circulation; 2000 Nov; 102(20):2491-6. PubMed ID: 11076822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels.
    Zhu J; Quyyumi AA; Norman JE; Csako G; Epstein SE
    J Am Coll Cardiol; 1999 Nov; 34(6):1738-43. PubMed ID: 10577564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relation between local CMV infection and inflammatory cytokine expressionon in pts sheduled for CABG].
    Fudal M; Domal-Kwiatkowska D; Kuczaj A; Ryfiński B; Sliupkas-Dyrda E; Wilczewski P; Smolik S; Weglarz L; Mazurek U; Nowalany-Kozielska E
    Wiad Lek; 2010; 63(4):276-88. PubMed ID: 21612043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy.
    Zhou YF; Leon MB; Waclawiw MA; Popma JJ; Yu ZX; Finkel T; Epstein SE
    N Engl J Med; 1996 Aug; 335(9):624-30. PubMed ID: 8687516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease.
    Al-Ghamdi A; Jiman-Fatani AA; El-Banna H
    Pak J Pharm Sci; 2011 Apr; 24(2):95-101. PubMed ID: 21454155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus infection is associated with elevated interleukin-10 in coronary artery disease.
    Sun Y; Pei W; Welte T; Wu Y; Ye S; Yang Y
    Atherosclerosis; 2005 Mar; 179(1):133-7. PubMed ID: 15721019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evidence against the effect of chronic cytomegalovirus infection in unstable angina pectoris.
    Alavi SM; Adel SM; Rajabzadeh AR
    Acta Med Iran; 2011; 49(2):78-80. PubMed ID: 21598213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus infection and coronary heart disease: results of a german case-control study.
    Rothenbacher D; Hoffmeister A; Bode G; Wanner P; Koenig W; Brenner H
    J Infect Dis; 1999 Mar; 179(3):690-2. PubMed ID: 9952378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis.
    Blum A; Giladi M; Weinberg M; Kaplan G; Pasternack H; Laniado S; Miller H
    Am J Cardiol; 1998 Apr; 81(7):866-8. PubMed ID: 9555776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease.
    Freedman B
    Circulation; 2001 Jul; 104(5):E20-1. PubMed ID: 11479266
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease.
    Rothenbacher D; Brenner H; Mertens T; Hoffmann MM; Hoffmeister A; Koenig W
    BMC Cardiovasc Disord; 2005 May; 5(1):10. PubMed ID: 15943888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of cytomegalovirus seropositivity and risk of mortality from diabetes.
    Mendy A; Gasana J; Vieira ER; Diallo H
    Acta Diabetol; 2014 Oct; 51(5):723-9. PubMed ID: 24633860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No relation between CMV infection and mortality in the oldest old: results from the Belfrail study.
    Matheï C; Adriaensen W; Vaes B; Van Pottelbergh G; Wallemacq P; Degryse J
    Age Ageing; 2015 Jan; 44(1):130-5. PubMed ID: 25026957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.
    Held C; White HD; Stewart RAH; Budaj A; Cannon CP; Hochman JS; Koenig W; Siegbahn A; Steg PG; Soffer J; Weaver WD; Östlund O; Wallentin L;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?
    Bruminhent J; Thongprayoon C; Dierkhising RA; Kremers WK; Theel ES; Razonable RR
    Liver Transpl; 2015 Apr; 21(4):539-46. PubMed ID: 25597303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cytomegalovirus sero-status in the development of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes.
    Guech-Ongey M; Brenner H; Twardella D; Hahmann H; Rothenbacher D
    Int J Cardiol; 2006 Jul; 111(1):98-103. PubMed ID: 16229909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.